|
시장보고서
상품코드
2148743
액티브 창상관리 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Active Wound Care Market, By Product Type, By Application, By End User, By Geography |
||||||
액티브 창상관리 시장 규모는 2026년에 20억 4,000만 달러로 추계되고 있으며, 2033년까지 30억 2,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 5.8%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 20억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 5.80% | 2033년 시장 규모 예측 : | 30억 2,000만 달러 |
‘능동적 상처 관리’란, 주로 상처를 보호하는 역할을 하는 수동적 드레싱과 대조적으로, 상처 치유의 자연스러운 과정을 능동적으로 유도하거나 촉진하는 고급 치료 솔루션의 사용을 의미합니다. 이 시장에는 급성 및 만성 상처에서 조직 재생, 세포 활동, 상처 폐쇄를 촉진하는 피부 대체재, 바이오소재, 성장인자 및 기타 재생 의학 제품이 다수 존재합니다.
전 세계 능동적 상처 관리 시장은 당뇨병성 족부 궤양, 욕창, 정맥성 하지 궤양 및 기타 만성 상처로 인한 부담 증가와 더불어, 바이오소재, 조직 공학, 재생 의학 분야의 기술적 진보에 힘입어 성장하고 있습니다. 첨단 치유 기술에 대한 임상적 수용도가 높아지고, 근본적인 치유 과정을 표적으로 하는 치료법으로의 전환이 능동적 상처 관리 솔루션에 대한 수요를 더욱 부추기고 있습니다.
시장 역학
전 세계 능동적 상처 관리 시장은 당뇨병 유병률의 상승, 고령 인구 증가, 그리고 첨단 상처 치유 요법의 채택 확대에 힘입어 성장하고 있습니다. 바이오소재, 조직 공학, 성장인자 요법, 피부 대체재의 발전 또한 임상적 수용도와 치료 결과의 향상에 기여하고 있습니다.
그러나 높은 치료 비용, 엄격한 규제 요건, 전문적인 교육 부족 등 시장에 몇 가지 제약 요인이 존재합니다. 그럼에도 불구하고 디지털 상처 모니터링, 인공지능(AI) 기반 창상 평가, 그리고 줄기세포 및 엑소좀 치료와 같은 재생의료 기술의 통합을 통해 새로운 시장 성장의 길이 열리고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 규명하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 활동성 상처 관리 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 얻은 인사이트를 바탕으로 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 ‘글로벌 능동적 상처 관리 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 능동적 상처 관리 시장 분석에 사용된 다양한 전략 매트릭스를 활용하여 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 액티브 창상관리 시장 : 제품 유형별, 2021-2033년
제5장 세계의 액티브 창상관리 시장 : 용도별, 2021-2033년
제6장 세계의 액티브 창상관리 시장 : 최종사용자별, 2021-2033년
제7장 세계의 액티브 창상관리 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KSA 26.10.20Active Wound Care Market is estimated to be valued at USD 2.04 Bn in 2026 and is expected to reach USD 3.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.04 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 3.02 Bn |
Active wound care refers to the utilization of high-end therapeutic solutions that actively induce or hasten the natural process of wound healing as opposed to passive dressings that mainly serve to protect the wound. The market is populated with skin substitutes, biomaterials, growth factors and other regenerative therapies that facilitate tissue regeneration, cellular activity and wound closure in acute and chronic wounds.
The global active wound care market is driven by the rising burden of diabetic foot ulcers, pressure ulcers, venous leg ulcers and other chronic wounds along with technological advances in biomaterials, tissue engineering and regenerative medicine. Growing clinical acceptance of advanced healing technologies and a move toward therapies targeting the underlying healing process further drives demand for active wound-care solutions.
Market Dynamics
The global active wound care market is driven by the rising prevalence of diabetes, a growing geriatric population and increasing adoption of advanced wound-healing therapies. Advances in biomaterials, tissue engineering, growth factor therapies and skin substitutes are also helping to increase clinical acceptance and treatment outcomes.
However, a number of constraints are present in the market, such as high treatment costs, stringent regulatory requirements, and lack of specialist training. Nevertheless, integration of digital wound monitoring, artificial intelligence-based wound assessment, and regenerative medicine technologies such as stem cell and exosome therapies is opening up new market growth avenues.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global active wound care market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Smith+Nephew plc, Organogenesis Inc., Integra LifeSciences Holdings Corporation, MiMedx Group, Inc., Tissue Regenix Group plc, Stryker Corporation, Solventum Corporation, Molnlycke Health Care AB, Aroa Biosurgery Limited, and Vericel Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global active wound care market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global active wound care market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Biomaterials
- Skin Substitutes
- Growth Factors
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Chronic Wounds
- Acute Wounds
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Wound Care Clinics
- Ambulatory Surgical Centers
- Home Healthcare
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Smith+Nephew plc
- Organogenesis Inc.
- Integra LifeSciences Holdings Corporation
- MiMedx Group, Inc.
- Tissue Regenix Group plc
- Stryker Corporation
- Solventum Corporation
- Molnlycke Health Care AB
- Aroa Biosurgery Limited
- Vericel Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Active Wound Care Market, By Product Type
- Global Active Wound Care Market, By Application
- Global Active Wound Care Market, By End User
- Global Active Wound Care Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Active Wound Care Market, By Product Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Skin Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Growth Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Active Wound Care Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Active Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Active Wound Care Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Wound Care Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Active Wound Care Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Smith+Nephew plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Organogenesis Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integra LifeSciences Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MiMedx Group, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tissue Regenix Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Solventum Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Molnlycke Health Care AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aroa Biosurgery Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
